The 9th Ocular Diseases Drug Discovery Conference is taking place on March 21-22, 2018 in San Diego, CA. We are excited to have top representatives from the industry and academic sectors to discuss technologies and targets that are continually changing the way ocular diseases are treated. Drug delivery is always improving as we look at for better methods to penetrate anterior and poster segments of the eye. Successes in gene therapy and regenerative medicine are proving to be interesting approaches to discuss in detail pre-clinically and clinically. We are gathering leading scientists, researchers, and experts to discuss and collaborate on combating and curing age-related macular degeneration (AMD), dry eye, glaucoma, diabetic macular edema (DME), and other ocular diseases.
- Novel Therapeutic Targets for Ocular Diseases
- Stem Cell and Gene Therapy for Ocular Diseases
- Combination Therapies for Ocular Diseases
- Recent Developments in Drug Delivery for Ocular Diseases
- Leveraging CROs to externalize R&D
- Business Development and Partnering
- Patient Adherence and Compliance
We hope to see you there!
The 2018 Advisory Committee
|2017 ADVISORY BOARD MEMBERS|
|Matthias Birkhoff, Aptar|
|Hongming Chen, Kalarx|
|Emmett Cunningham, Clarus Ventures|
|Rafal Farjo, EyeCRO LLC|
|Doug Fisher, InterWest|
|Glenn Noronha, Clearside Biomedical|
|Donald J. Alcendor, Vanderbilt University|
|Hongming Chen, Kala Pharmaceuticals|
Amber Kempf at 626-256-6405 or amber.kempf [at] gtcbio.com
The 2018 sponsorship is currently in process.
Please come back and visit this page for updates.
BELOW ARE THE SPONSORS FROM 2017.
Viracor Eurofins provides clinical trial biomarker testing services with expertise in custom assay transfer, design and validation for phase I-IV trials. Our CAP/CLIA and NY state accredited laboratory has over 30 years of experience in molecular testing, immune response monitoring, vaccine safety/efficacy assessment, allergy and hypersensitivity testing.
Cancer Genetics Inc. (CGI; Nasdaq: CGIX) is a leader in enabling precision medicine in oncology from bench to bedside through the use of oncology biomarkers and molecular testing. CGI is developing a global footprint with locations in the US, India and China. The Company offers a comprehensive range of laboratory services that provide critical genomic and biomarker information. Its state-of-the-art reference labs are CLIA-certified and CAP-accredited in the US and have licensure from several states including New York State. CGI has established strong clinical research collaborations with major cancer centers such as Memorial Sloan Kettering, The Cleveland Clinic, Mayo Clinic, Keck School of Medicine at USC and the National Cancer Institute.
Phoenix Research Labs’ imaging technologies are designed by scientists, for scientists, to support eye and eye-brain research using mice and rats. Our products are optimized for the rodent eye, leading to extraordinary performance and high quality images that enable a new area of in vivo observations.
Powered Research, LLC is a preclinical CRO that specializes in non-GLP swine, rabbit, and rodent models in the ophthalmic space. With our extensive expertise and quick turn-around time, we’ve helped multiple ocular companies with their R&D needs. In addition to in-life studies, we provide full bioanalytical and histology services in-house.
Ora is the world’s leading full-service ophthalmic CRO and product development firm with offices in the United States, the United Kingdom and Japan. Over the past 40 years, we have proudly helped our clients earn 44 product approvals. We support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Ora’s pre-clinical and clinical models, unique methodologies and regulatory strategies have been refined and proven across thousands of projects. We bring together the world’s most extensive and experienced team of ophthalmic experts and R&D professionals to maximize the value of new product initiatives.
Trial Runners is an ophthalmology CRO providing biotech and pharmaceutical companies with clinical research management services. We have worked on over 61 clinical studies researching innovative ways to manage or cure diseases related to the eye.